HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 3 of 19

‹View Table of Contents

Related Pages

Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type, Adults, 2018-2021

 

Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type, Adults, 2018-2021
Pathogens1 HAI Events2
HAI Type # % # %
SSI 215,669 47.6 190,384 47.4
CLABSI 113,604 25.1 100,851 25.1
CAUTI 107,934 23.8 96,974 24.2
PVAP 15,733 3.5 13,114 3.3
Total 452,940 100.0 401,323 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. Between 1-3 pathogens are required to be reported to NHSN for each CLABSI and CAUTI event. Between 0-3 pathogens can be reported to NHSN for each PVAP and SSI event.
  2. There were 46,099 SSIs and 403 PVAPs reported to NHSN without a pathogen from 2018 – 2021. These events are included in the event counts in Table 2.

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. ›Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type